Continuous Glucose Monitoring in Pregnant Women Undergoing Betamethasone Therapy

Trial ID or NCT#

NCT01165775

Status

not recruiting iconNOT RECRUITING

Purpose

We hope to clarify how betamethasone affects glucose levels in the mother in the days after receiving the drug. This understanding will hopefully allow us to better anticipate the risk of maternal hyperglycemia and therefore establish more appropriate monitoring of maternal glucose to prevent maternal and neonatal complications of hyperglycemia.

Official Title

Continuous Glucose Monitoring in Pregnant Women Undergoing Betamethasone Therapy

Eligibility Criteria

Ages Eligible for Study: 18 Years to 50 Years
Sexes Eligible for Study: FEMALE
Accepts Healthy Volunteers: No
Inclusion Criteria:
  1. - 18 years of age or older
    1. * Receiving betamethasone as part of routine clinical care.* Pregnancy between 23+5 and 35+0 weeks
Exclusion Criteria:
  1. - Less than 18 years old.* Major fetal anomalies* Use of steroid medications in the past 2 weeks.
View All Criteria
Show Less

Investigator(s)

Yasser El-Sayed, Professor
Yasser El-Sayed, Professor
Obstetrician and Gynecologist (OB-GYN)
Charles B. and Ann L. Johnson Professor in the School of Medicine and Professor, by courtesy, of Pediatrics (Neonatology) and of Surgery

Contact us to find out if this trial is right for you.

Contact

Yasser El-Sayed
6507233198

View on ClinicalTrials.gov